FTC Urges Pay-For-Delay Limits To Ease Deficit Woes
U.S. Federal Trade Commission Chairman Jon Leibowitz on Monday urged Congress to restrict pay-for-delay drug patent settlements that the agency has long criticized as anti-competitive, in order to lower federal deficits...To view the full article, register now.
Already a subscriber? Click here to view full article